GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets

Glioblastoma multiforme (GBM) is the most aggressive and deadly brain tumor, portending a median 13-month survival even following gross total resection with adjuvant chemotherapy and radiotherapy. This prognosis necessitates improved therapies for the disease. A target of interest for novel chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Guda, Maheedhara R., Labak, Collin M., Omar, Sara Ibrahim, Asuthkar, Swapna, Airala, Subra, Tuszynski, Jack, Tsung, Andrew J., Velpula, Kiran K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771132/
https://www.ncbi.nlm.nih.gov/pubmed/31491891
http://dx.doi.org/10.3390/cancers11091308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771132/
https://www.ncbi.nlm.nih.gov/pubmed/31491891
http://dx.doi.org/10.3390/cancers11091308

Ejemplares similares